Safety of pertussis vaccination in pregnant women in UK: Observational study

BMJ (Online)

Volumn 349, Issue , 2014, Pages

  Donegan, Katherine ^a   King, Bridget ^a   Bryan, Phil ^a  

^a MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG SAFETY; ECLAMPSIA; FEMALE; FETUS DISTRESS; GESTATIONAL AGE; HUMAN; HUMAN EXPERIMENT; KIDNEY FAILURE; LOW BIRTH WEIGHT; MORBIDITY; MORTALITY; NORMAL HUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERTUSSIS; PLACENTA PREVIA; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STILLBIRTH; UNITED KINGDOM; UTERUS RUPTURE; VACCINATION;

ADULT; COHORT STUDIES; FEMALE; GREAT BRITAIN; HUMANS; PERTUSSIS VACCINE; PREGNANCY; PREGNANT WOMEN; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STILLBIRTH;

EID: 84904254589     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g4219     Document Type: Article

References (23)

1. Crowcroft NS and Pebody RG. Recent developments in pertussis. Lancet 2006;367:1926-36. (Pubitemid 43831996)
2. The complete routine immunisation schedule 2013/2014. Public Health England, 2013. www.gov.uk/government/publications/the-complete-routine- immunisation-schedule-201314.
3. NHS Immunisation Statistics, England 2011-12. NHS Information Centre for Health and Social Care, 2013. https://catalogue.ic.nhs.uk/publications/public- health/immunisation/nhs-immu-stat-eng-2011-2012/nhs-immu-stat-eng-2011-12-rep. pdf.
4. Health Protection Agency. Laboratory-confirmed cases of pertussis reported to the enhanced pertussis surveillance programme (England and Wales). Health Protection Report 2012;6(8). www.hpa.org.uk/hpr/archives/2012/hpr0812. pdf.
5. Joint Committee on Vaccination and Immunisation. Minutes of teleconference on Thursday 30 August 2012 10.00am - 12.00am and post-teleconference discussion www.gov.uk/government/uploads/system/uploads/ attachment-data/file/223497/JCVI-minutes-Aug-2012-Pertussis---final.pdf.
6. Casey JR, Pichichero ME. Acellular pertussis vaccine safety in children, adolescents, and adults. Drugs 2005;65:1637-89.
7. Keital WA, Muenz LR, Decker MD, Englund JA, Mink CM, Blumberg DA, et al. A randomized controlled trial of acellular pertussis vaccines in healthy adults: dose-response comparisons of 5 vaccines and implications for booster immunization. J Infect Dis 1999;180:397-403. (Pubitemid 30256321)
8. Zheteyeva YA, Moro PL, Tepper NK, Rasmussen SA, Barash FE, Revzina NV, et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol 2012;207:59.e1-7.
9. Global Advisory Committee on Vaccine Safety. World Health Organization. Weekly Epidemiological Record 2013;29:301-12.
10. Advisory Committee on Immunization Practices. Updated recommendation for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant <12 months. ACIP, 2011. www.cdc.gov/mmwr/preview/ mmwrhtml/mm6041a4.htm.
11. Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol 2011;204:334.e1-5.
12. Gelfand JM, Margolis DJ, Dattani H. The UK general practice research database. In: Strom BL, ed. Pharmacoepidemiology. 4th ed. John Wiley, 2005:337-46.
13. Sammon CJ, McGrogan A, Snowball J, de Vries CS. Pandemic influenza vaccination during pregnancy: an investigation of vaccine uptake during the 2009/10 pandemic vaccination campaign in Great Britain. Hum Vaccin Immunother 2013;9:917-23.
14. Joint Committee on Vaccination and Immunisation. Minutes of the meeting on Wednesday 6 February 2013 www.gov.uk/government/uploads/system/uploads/ attachment-data/file/223498/JCVI-minutes-February-2013-meeting---final. pdf---final.pdf.
15. Devine S, West S, Andrews E, Tennis P, Hammad TA, Eaton S, et al. The identification of pregnancies within the general practice research database. Pharmacoepidemiol Drug Saf 2010;19:45-50.
16. Boggon R, Gallagher A, Williams T, van Staa T. Creating a mother baby link and pregnancy register for a UK population. Pharmacoepidemiol Drug Saf 2011;20:S44.
17. Gestation-specific infant mortality in England and Wales, 2010. Office for National Statistics. www.ons.gov.uk/ons/rel/child-health/gestation-specific- infant-mortality-in-england-and-wales/2010/rft-1-2010.xls.
18. Infant and perinatal mortality in England and Wales by social and biological factors, 2011. Office for National Statistics. www.ons.gov.uk/ons/ rel/child-health/infant-and-perinatal-mortality-in-england-and-wales-by-social- and-biological-factors/2011/stb-infant-and-perinatal-mortality-2011.html.
19. Tuffnell DJ, Jankowicz D, Lindow SW, Lyons G, Mason GC, Russell IF, et al. Outcomes of severe pre-eclampsia/eclampsia in Yorkshire 1999/2003. BJOG 2005;112:875-80. (Pubitemid 40896951)
20. Knight M, UKOSS. Eclampsia in the United Kingdom 2005. Br J Obstet Gynaecol 2007;114:1072-8. (Pubitemid 47247026)
21. Pertussis vaccination programme for pregnant women 2012 to 2014: monthly data by area team (England). www.gov.uk/government/uploads/system/uploads/ attachment-data/file/308699/PertussisVaccineCoverage-Oct2012-Mar2014-acc2.pdf.
22. Advisory Committee on Immunization Practices. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccine (Tdap) in pregnant women. ACIP, 2012. www.cdc.gov/mmwr/preview/mmwrhtml/ mm6207a4.htm.
23. Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014 (in press).